Clinical Diagnostics Laboratory Segment | Other Segment | Total | |||||||||||||||||||||
December 31, 2013 | December 31, 2012 | December 31, 2013 | December 31, 2012 | December 31, 2013 | December 31, 2012 | ||||||||||||||||||
Balance as of January 1 | $ | 2,857.1 | $ | 2,643.5 | $ | 44.6 | $ | 38.3 | $ | 2,901.7 | $ | 2,681.8 | |||||||||||
Goodwill acquired during the period | 107.5 | 219.1 | 19.5 | 5.4 | 127.0 | 224.5 | |||||||||||||||||
Adjustments to goodwill | (4.4 | ) | (5.5 | ) | (1.5 | ) | 0.9 | (5.9 | ) | (4.6 | ) | ||||||||||||
Balance at end of period | $ | 2,960.2 | $ | 2,857.1 | $ | 62.6 | $ | 44.6 | $ | 3,022.8 | $ | 2,901.7 |
December 31, 2013 | December 31, 2012 | ||||||||||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||
Customer relationships | $ | 1,327.0 | $ | (545.1 | ) | $ | 781.9 | $ | 1,296.1 | $ | (483.3 | ) | $ | 812.8 | |||||||||
Patents, licenses and technology | 116.2 | (85.4 | ) | 30.8 | 117.2 | (76.2 | ) | 41.0 | |||||||||||||||
Non-compete agreements | 41.6 | (25.3 | ) | 16.3 | 32.3 | (19.6 | ) | 12.7 | |||||||||||||||
Trade names | 131.4 | (83.0 | ) | 48.4 | 131.3 | (73.4 | ) | 57.9 | |||||||||||||||
Canadian licenses | 694.6 | — | 694.6 | 743.3 | — | 743.3 | |||||||||||||||||
$ | 2,310.8 | $ | (738.8 | ) | $ | 1,572.0 | $ | 2,320.2 | $ | (652.5 | ) | $ | 1,667.7 |
Amount | Weighted Average Amortization Period | ||||
Customer relationships | $ | 31.6 | 16.2 | ||
Non-compete agreements | 9.3 | 5.0 | |||
$ | 40.9 | 13.7 |